MDS Pharma Ad
Will Generative AI Live Up to its High Expectations in Healthcare?
Research shows GenAI has greater potential for a more immediate impact than previous digital technologies implemented in healthcare.
Combining Awareness and Innovation
Jared Baeten, Vice President, Clinical Development, HIV Franchise Head at Gilead Sciences highlights how awareness and clinical innovation have transformed research in the HIV space.
Study Finds Low Representation of Disabled Participants in Cardiac Clinical Trials
Despite regulatory guidance, disability status is frequently unreported or overlooked in trial design.
SCOPE EUROPE 2023 Recap
Insightful sound bytes from KOLs attending SCOPE EUROPE 2023.
Promising Trial Data Lead to FDA Fast Track Designation for Breast Cancer Combination Therapy
FDA grants to expedite review of zotatifin plus Faslodex (fulvestrant) and Verzenio (abemaciclib) for patients with ER–positive, HER2-negative advanced or metastatic breast cancer.
FDA Warns of Rare But Serious Reaction to Antiseizure Medications
Included in the FDA warning were levetiracetam, under the brand names Keppra and Keppra XR; Elepsia XR; Spritam; and clobazam, under the brand names Onfi and Sympazan.
2 Clarke Drive Cranbury, NJ 08512